Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2022-12-28T10:48:48+01:0022/10/2022| Lire la suite
One last effort. Are high out‑of‑pocket payments at the end of life a fatality? Jessica LAUBERT2022-08-05T15:31:20+01:0031/01/2022| Lire la suite
Knowledge about own complementary health insurance plan and healthcare consumption: do the health insured get their money’s worth? Jessica LAUBERT2021-12-17T15:21:48+01:0003/12/2021| Lire la suite